Scott Applebaum serves as Executive at MEDGENICS, INC., where they oversee executive responsibilities. Since joining the company, Scott Applebaum has executed 4 insider transactions totaling $25.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 10, 2021 involved selling 21,178 shares valued at $60.4K.
Scott Applebaum currently holds 344,022 shares of MEDGENICS, INC. (MDGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Applebaum has been a net buyer of MDGN stock. They have purchased $25.0K and sold $0 worth of shares.
Scott Applebaum's most recent insider trade was on Feb 10, 2021, when they sold 21,178 shares at $2.85 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 10, 2020 | TRVN | $0 | Award | 250,000 | $N/A | Discretionary |
| Dec 1, 2014 | MDGN | $25.0K | Purchase | 6,098 | $4.10 | Discretionary |